KYOWA Trademark

Trademark Overview


On Thursday, March 17, 2022, a trademark application was filed for KYOWA with the United States Patent and Trademark Office. The USPTO has given the KYOWA trademark a serial number of 79341532. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, October 16, 2023. This trademark is owned by Kyowa Kirin Co., Ltd.. The KYOWA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer or malignant tumors, pain, hematological disorders, renal disease, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders; pharmaceutical preparations for supportive care in the treatment of cancer or malignant tumors; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes; cell culture mediums for medical and veterinary purposes; reagent paper for medical purposes
kyowa

General Information


Serial Number79341532
Word MarkKYOWA
Filing DateThursday, March 17, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, October 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer or malignant tumors, pain, hematological disorders, renal disease, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders; pharmaceutical preparations for supportive care in the treatment of cancer or malignant tumors; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes; cell culture mediums for medical and veterinary purposes; reagent paper for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKyowa Kirin Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Thursday, June 2, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, June 8, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 14, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, February 14, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 15, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, April 3, 2023REFUSAL PROCESSED BY MPU
Monday, April 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 16, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, April 25, 2023REFUSAL PROCESSED BY IB
Monday, October 16, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, October 16, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, November 8, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 8, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, November 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, October 17, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 17, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB